Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]

Hinz M, Stein A, Neff R,Weinberg R, Uncini T. Neuropsych Dis Treat. 2011;7:31–38. The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hinz M, Stein A, Neff R, Weinberg R, Uncini T
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/f86369b6bc254695b13742acd6aa9157
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f86369b6bc254695b13742acd6aa9157
record_format dspace
spelling oai:doaj.org-article:f86369b6bc254695b13742acd6aa91572021-12-02T11:48:14ZTreatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]1178-2021https://doaj.org/article/f86369b6bc254695b13742acd6aa91572020-04-01T00:00:00Zhttps://www.dovepress.com/eoc-treatment-of-attention-deficit-hyperactivity-disorder-with-monoami-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Hinz M, Stein A, Neff R,Weinberg R, Uncini T. Neuropsych Dis Treat. 2011;7:31–38. The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors, and the level of information provided on methodology, study data and process of institutional ethical approval for the published article. Neuropsychiatric Disease and Treatment would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation. The authors have been informed of these concerns and of our investigation. Read the original article  Hinz MStein ANeff RWeinberg RUncini TDove Medical Pressarticleadhd5-htptyrosinel-dopaoct assay interpretationNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 1067-1068 (2020)
institution DOAJ
collection DOAJ
language EN
topic adhd
5-htp
tyrosine
l-dopa
oct assay interpretation
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle adhd
5-htp
tyrosine
l-dopa
oct assay interpretation
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Hinz M
Stein A
Neff R
Weinberg R
Uncini T
Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]
description Hinz M, Stein A, Neff R,Weinberg R, Uncini T. Neuropsych Dis Treat. 2011;7:31–38. The Editor-in-Chief and Publisher of Neuropsychiatric Disease and Treatment wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors, and the level of information provided on methodology, study data and process of institutional ethical approval for the published article. Neuropsychiatric Disease and Treatment would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation. The authors have been informed of these concerns and of our investigation. Read the original article  
format article
author Hinz M
Stein A
Neff R
Weinberg R
Uncini T
author_facet Hinz M
Stein A
Neff R
Weinberg R
Uncini T
author_sort Hinz M
title Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]
title_short Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]
title_full Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]
title_fullStr Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]
title_full_unstemmed Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]
title_sort treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation [expression of concern]
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/f86369b6bc254695b13742acd6aa9157
work_keys_str_mv AT hinzm treatmentofattentiondeficithyperactivitydisorderwithmonoamineaminoacidprecursorsandorganiccationtransporterassayinterpretationexpressionofconcern
AT steina treatmentofattentiondeficithyperactivitydisorderwithmonoamineaminoacidprecursorsandorganiccationtransporterassayinterpretationexpressionofconcern
AT neffr treatmentofattentiondeficithyperactivitydisorderwithmonoamineaminoacidprecursorsandorganiccationtransporterassayinterpretationexpressionofconcern
AT weinbergr treatmentofattentiondeficithyperactivitydisorderwithmonoamineaminoacidprecursorsandorganiccationtransporterassayinterpretationexpressionofconcern
AT uncinit treatmentofattentiondeficithyperactivitydisorderwithmonoamineaminoacidprecursorsandorganiccationtransporterassayinterpretationexpressionofconcern
_version_ 1718395259972485120